Akari Therapeutics Plc (AKTX)
Score window: Apr. 15, 2025 to Apr. 14, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jan. 27, 2026 | CORRESP | Neutral/Informational | Moderate | Akari Therapeutics, Plc has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1, originally filed on January 23, 2026. They… | Read Filing EDGAR |
| Jan. 27, 2026 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Akari Therapeutics that they will not review the company's registration statement filed on January 23, 2026. The letter emphasizes that the responsibil… | Read Filing EDGAR |
| Dec. 1, 2025 | CORRESP | Neutral/Informational | Moderate | Akari Therapeutics, Plc has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1, originally filed on November 17, 2025. The… | Read Filing EDGAR |
| Jul. 30, 2025 | CORRESP | Neutral/Informational | Moderate | Akari Therapeutics PLC has submitted a request to the SEC for the acceleration of the effectiveness of their Registration Statement on Form S-3. They are seeking to have the state… | Read Filing EDGAR |
| Jul. 30, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Akari Therapeutics that they will not review the company's registration statement filed on July 29, 2025. This correspondence emphasizes the company's … | Read Filing EDGAR |
| May. 12, 2025 | CORRESP | Neutral/Informational | Moderate | Akari Therapeutics, Plc has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-3, originally filed on May 6, 2025. The compa… | Read Filing EDGAR |
| May. 9, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to Akari Therapeutics that it will not review their registration statement filed on May 6, 2025. The letter emphasizes the company's responsibility for th… | Read Filing EDGAR |